Colorectal Cancer

Predicting drug response in colorectal cancer.

KRAS gene mutations are detected in various cancers, including colorectal.

A timeline of KRAS research.

Issues after surgery can be taxing for patient and caregiver.

Colorectal cancer survivors take their message to Congress.

Fighting colon cancer was only part of the battle; this survivor then had to learn how, and what, to eat all over again.

Side effect may predict response to treatment.

A number of diagnostic, prognostic, or predictive tests can help determine the optimal course of treatment by using predictive markers from the patient’s or tumor’s genetic information.

The FDA approves third kidney cancer drug and blood-clotting therapy while delaying review on a prostate cancer vaccine, and one drug edges another in a colorectal cancer clinical trial.

Updates from the 2007 meeting of the American Society of Clinical Oncology includes news on liver, kidney, lung, colon, pancreatic and breast cancers.

More coverage means more people are screened, and colon cancers are caught earlier.

This article discusses genetic test kits and the types of cancer they test for.

New approvals for colorectal, lung, breast, head & neck cancer and lymphoma.

The individual & family decisions behind testing for genetic cancer risk.

Learning about one's genetic status may open a Pandora's box of personal and familial issues.

Chemoprevention options exist for individuals with high risk of breast, prostate, or colorectal cancers.

Survivors guided through territory of long-term and late effects.

How to help children deal with the fear of their parents’ cancer.

In addition to treatment-related risks, some survivors discover they have a genetic syndrome that may lead to a second cancer.

Young adult survivor Molly McMaster turns her experience into a national tour and non-profit group dedicated to raising awareness on colon cancer.